Abiomed ประกาศรายได้ไตรมาสที่ 1 ปีงบประมาณ 2561 จำนวน 132.5 ล้านดอลลาร์สหรัฐ เพิ่มขึ้นร้อยละ 29 จากปีก่อน
July 28, 2017 09:35 ET
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) ผู้ให้บริการชั้นนำด้านเทคโนโลยีอันก้าวหน้าในด้านการสนับสนุนหัวใจได้รายงานในวันนี้เกี่ยวกับรายได้ประจำไตรมาสแรกปีงบประมาณ...
Abiomed宣佈2018會計年度第1季營收1.325億美元，較去年成長29%
July 28, 2017 09:35 ET
|
Abiomed
麻州丹弗斯, July 28, 2017 (GLOBE NEWSWIRE) -- 流的劃時代心臟保健科技供應商Abiomed, Inc.（Nasdaq:...
Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
July 27, 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
Abiomed First Quarter Fiscal 2018 Earnings and Conference Call Notification
July 06, 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
June 30, 2017 08:04 ET
|
Abiomed
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
June 09, 2017 08:07 ET
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
Abiomed to Present at the Jefferies Healthcare Conference
May 30, 2017 08:00 ET
|
Abiomed
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
May 09, 2017 09:33 ET
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
Abiomed 宣布 2017 财年第 四季度收入达到的 1.247 亿美元，比上一年度增长 33%，全年收入 4.453 亿美元，比上一年度增长 35%
May 08, 2017 10:44 ET
|
Abiomed
马萨诸塞州丹佛斯, May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed 公司（纳斯达克编号：ABMD）是突破性心脏支架技术的领先供应商，它今天宣布 2017 财年第四季度收入达到 1.247 亿美元，比 2016 年同期的 9,400 万美元收入增长 33%。2017 财年的总收入为 4.453 亿美元，比 2016 年的 3.295 亿美元收入增长 35%。在...
アビオメッド(Abiomed)、2017年度第4四半期の収入は前年比33%増の1億2,470万ドル、通年の収入は前年比35%増の4億4,530ドル
May 08, 2017 10:44 ET
|
Abiomed
マサチューセッツ州ダンバース発, May 08, 2017 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダー、アビオメッド (Abiomed, Inc.、NASDAQ:ABMD) は本日、2017年度第4四半期に1億2,470万ドル (約140億5,600万円) の収入を計上し、2016年度同期の9,400万ドル (約105億9,600万円)...